Entomed SA

The French government has always been vocal about its desire to turn France into a leader in innovation and high tech industries. On the pharma side, it certainly influenced heavily the success of San

Neuro3d's €31.5 million third round late in 2004 was one of France's largest private biotech financings for years. But none of the investors are looking to France to provide the exit opportunities, wh

Acquisitions Novartis gets majority stake in Idenix for CHF352.7mm Novartis AG (Basel, Switzerland) Novartis Pharma AG Idenix Pharmaceuticals Inc. (Cambridge, MA) Novartis Pharma AG paid CHF352.7m

Opportunistic Infections mean Opportunities for Start-Ups Former movie mogul Samuel Goldwyn once said, "A hospital is no place to be sick," and he was right. The US Centers for Disease Control (CDC) r